Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $5.88 million on Aug 06 ’25. In the deal valued at $42.02 per share,140,000 shares were sold. As a result of this transaction, Khattar Jack A. now holds 1,030,183 shares worth roughly $41.79 million.
Then, JACK A KHATTAR bought 140,000 shares, generating $5,254,200 in total proceeds.
Before that, Rubin Jonathan sold 927 shares. Supernus Pharmaceuticals Inc shares valued at $36,292 were divested by the SVP, Chief Medical Officer at a price of $39.15 per share. As a result of the transaction, Rubin Jonathan now holds 7,853 shares, worth roughly $0.32 million.
Cantor Fitzgerald upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “a Neutral”. Cantor Fitzgerald began covering SUPN with “an Overweight” recommendation on January 06, 2025. Piper Sandler revised its rating on September 11, 2024. It rated SUPN as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of SUPN
On Monday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock fall -1.60% to $40.57. Over the last five days, the stock has gained 9.50%. Supernus Pharmaceuticals Inc shares have risen nearly 27.10% since the year began. Nevertheless, the stocks have risen 12.20% over the past one year. While a 52-week high of $43.62 was reached on 08/06/25, a 52-week low of $29.16 was recorded on 05/07/25.
Levels Of Support And Resistance For SUPN Stock
The 24-hour chart illustrates a support level at 40.06, which if violated will result in even more drops to 39.55. On the upside, there is a resistance level at 41.34. A further resistance level may holdings at 42.11.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-07-15, growing by 1.07 million shares to a total of 5.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.03 million shares. There was a rise of 20.96%, which implies that there is a positive sentiment for the stock.
